|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income/(loss) | |||||
| Adjustments to reconcile net income/(loss) to net cash flows | |||||
| Depreciation of property and equipment and lease right-of-use assets | |||||
| Amortization of intangible assets | |||||
| Excess and obsolete reserve | |||||
| Impairment charges on real estate assets | |||||
| Write-off of content assets | |||||
| Share-based compensation expense | |||||
| Finance income | |||||
| Finance costs | |||||
| Income tax expense | |||||
| Other | |||||
| Changes in working capital: | |||||
| (Increase)/decrease in trade receivables and other assets | |||||
| Increase in trade and other liabilities | |||||
| Increase in deferred revenue | |||||
| Increase/(decrease) in provisions | |||||
| Interest paid on lease liabilities | |||||
| Interest paid | |||||
| Interest received | |||||
| Income tax paid | |||||
| Net cash flows from operating activities | |||||
| Investing activities | |||||
| Business combinations, net of cash acquired | |||||
| Payment of deferred consideration pertaining to business combinations | |||||
| Purchases of property and equipment | |||||
| Purchases of short term investments | |||||
| Sales and maturities of short term investments | |||||
| Change in restricted cash | |||||
| Dividends received | |||||
| Other | |||||
| Net cash flows used in investing activities | |||||
| Financing activities | |||||
| Payments of lease liabilities | |||||
| Lease incentives received | |||||
| Repurchases of ordinary shares | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of warrants | |||||
| Proceeds from issuance of Exchangeable Notes, net of costs | |||||
| Payments for employee taxes withheld from restricted stock unit releases | |||||
| Net cash flows (used in)/from financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at January 1 | |||||
| Net foreign exchange (losses)/gains on cash and cash equivalents | |||||
| Cash and cash equivalents at December 31 | |||||
| Supplemental disclosure of cash flow information | |||||
| Non-cash investing and financing activities | |||||
| Deferred consideration liability recognized in conjunction with business combination | |||||
| Recognition of lease right-of-use asset in exchange for lease liabilities | |||||
| Real estate assets disposed of in exchange for finance lease receivables | |||||
| Purchases of property and equipment in trade and other liabilities | |||||
| Employee taxes withheld from restricted stock unit releases in trade and other liabilities | |||||
| Issuance of ordinary shares upon net settlement of warrants | |||||
Loading...